Industry
Distribution Agreement Will Streamline Methotrexate Determinations
Measurement of levels of the anticancer and anti-autoimmune disease drug methotrexate in human serum or plasma will be streamlined by the integration of a quantitative methotrexate assay into the menu of a popular line of clinical chemistry autoanalyzers. More...16 Nov 2014
Blood Sector Continues to Experience Solid Growth
The global blood industry has experienced strong growth in recent years and growth will remain solid though 2018, according to the new report, "Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products," from healthcare market researcher Kalorama Information. More...10 Nov 2014
Tumor BRAC Analysis CDx Lab Established in Europe
Myriad Genetics has announced the establishment of a Tumor BRACAnalysis CDx laboratory in Europe in which Myriad's next-generation Tumor BRACAnalysis CDx test will identify many more ovarian cancer patients who may benefit from treatment with PARP inhibitors, such as olaparib. More...04 Nov 2014
Ventana to Develop Companion Diagnostics for ImmunoGen Anticancer Agents
Ventana Medical Systems, member of the Roche Group, has announced a collaboration agreement with ImmunoGen to develop biomarker assays and a companion diagnostic immunohistochemistry test for one or more of ImmunoGen's product candidates. More...03 Nov 2014
.jpg)
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Urine Analyzer
respons® UDS100
In Other News
ERBA Diagnostics Enters Brazilian Sector with Leading-Edge Clinical Testing Portfolio
French-German Cooperation to Improve Personalized Cancer Care
BD Advances Entry into NGS with Acquisition of GenCell Biosystems
GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion
Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions
Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease
First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing
Physician Office IVD Sector Nears USD 2.5 Billion
Newly CE-Marked Automated Respiratory Disease Assay Now Available
Illumina Partners with Pharmaceutical Companies to Develop Companion Diagnostics
Companion Testing Sector Increased Significantly in 2013
New Partnership Designed to Automate Dystrophin Measurement
Most IVD Sector Companies Look Outside the EU and USA for Growth
Rheonix and Life Technologies Introduce Molecular Testing Platform
Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide
Leica Biosystems Acquires Kreatech Diagnostics
Ventana Paves the Way for High-Standard Companion Diagnostic Clinical Trials Services in China
German Court Finds in Favor of Puritan in Patent Infringement Case
Genomic Biomarkers Assess Treatment Prognosis in Blood Cancers
EKF Wins Distribution Contract and Regulatory Approval for Target Regions
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
